CXCR4 and prostate carcinoma: Conversely, in prostate cancer where CXCR4 strongly regulates the development of metastasis, treatment of prostate cells with dihydrotestosterone increased the expression of the androgen receptor, CXCR4, PI3K and AKT phosphorylation as well as EMT and downstream cell cycle control genes.